<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10980000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q05940</UniProt_ID>
  <Seq_Length>514</Seq_Length>
  <Molecule_Weight>55713</Molecule_Weight>
  <KEGG_ID>hsa:6571</KEGG_ID>
  <Orthology_ID>K08155</Orthology_ID>
  <Function_Summary>Involved in the ATP-dependent vesicular transport of biogenic amine neurotransmitters. Pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Requisite for vesicular amine storage prior to secretion via exocytosis.</Function_Summary>
  <Pfam_ID>PF07690:MFS_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Monoamine transporter</Alias>
      <Alias>Solute carrier family 18 member 2</Alias>
      <Alias>Vesicular amine transporter 2</Alias>
      <Alias>VAT2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of amines, including polyamines, from one side of the membrane to the other. Amines are organic compounds that are weakly basic in character and contain an amino (-NH2) or substituted amino group.</Detail>
      <Keyword>Amine transmembrane transporter activity</Keyword>
      <Ontology_ID>GO:0005275</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of monoamines, organic compounds that contain one amino group that is connected to an aromatic ring by an ethylene group (-CH2-CH2-), from one side of the membrane to the other.</Detail>
      <Keyword>Monoamine transmembrane transporter activity</Keyword>
      <Ontology_ID>GO:0008504</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of serotonin from one side of the membrane to the other. Serotonin (5-hydroxytryptamine) is a monoamine neurotransmitter occurring in the peripheral and central nervous systems.</Detail>
      <Keyword>Serotonin transmembrane transporter activity</Keyword>
      <Ontology_ID>GO:0015222</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin.</Detail>
      <Keyword>Insulin secretion</Keyword>
      <Ontology_ID>GO:0030073</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.</Detail>
      <Keyword>Response to starvation</Keyword>
      <Ontology_ID>GO:0042594</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.</Detail>
      <Keyword>Response to zinc ion</Keyword>
      <Ontology_ID>GO:0010043</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Negative regulation of neurotransmitter transport</Keyword>
      <Ontology_ID>GO:0051589</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The inherent decline over time, from the optimal fertility and viability of early maturity, that may precede death and may be preceded by other indications, such as sterility.</Detail>
      <Keyword>Aging</Keyword>
      <Ontology_ID>GO:0007568</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a herbicide stimulus. Herbicides are chemicals used to kill or control the growth of plants.</Detail>
      <Keyword>Response to herbicide</Keyword>
      <Ontology_ID>GO:0009635</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.</Detail>
      <Keyword>Locomotory behavior</Keyword>
      <Ontology_ID>GO:0007626</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.</Detail>
      <Keyword>Response to amphetamine</Keyword>
      <Ontology_ID>GO:0001975</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of membrane-bounded vesicles from recycling endosomes back to the plasma membrane where they are recycled for further rounds of transport.</Detail>
      <Keyword>Endocytic recycling</Keyword>
      <Ontology_ID>GO:0032456</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Cellular response to drug</Keyword>
      <Ontology_ID>GO:0035690</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A permanent cessation of all vital functions: the end of life; can be applied to a whole organism or to a part of an organism.</Detail>
      <Keyword>Death</Keyword>
      <Ontology_ID>GO:0016265</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.</Detail>
      <Keyword>Post-embryonic development</Keyword>
      <Ontology_ID>GO:0009791</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.</Detail>
      <Keyword>Response to cocaine</Keyword>
      <Ontology_ID>GO:0042220</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of amines, including polyamines, organic compounds containing one or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Amine transport</Keyword>
      <Ontology_ID>GO:0015837</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.</Detail>
      <Keyword>Glucose homeostasis</Keyword>
      <Ontology_ID>GO:0042593</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.</Detail>
      <Keyword>Neurotransmitter transport</Keyword>
      <Ontology_ID>GO:0006836</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.</Detail>
      <Keyword>Response to corticosterone stimulus</Keyword>
      <Ontology_ID>GO:0051412</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated release of neurotransmitter into the synaptic cleft. A neurotransmitter is any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, gamma-aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin.</Detail>
      <Keyword>Neurotransmitter secretion</Keyword>
      <Ontology_ID>GO:0007269</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus.</Detail>
      <Keyword>Cellular response to ammonium ion</Keyword>
      <Ontology_ID>GO:0071242</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>511</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>513</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYSIKHEKNATEIQTARPVHTASISDSFQSIFSYYDNSTMVTGNATRDLTLHQTATQHMVTNASAVPSDCPSEDKDLLNENVQVGLLFASKATVQLITNPFIGLLTNRIGYPIPIFAGFCIMFVSTIMFAFSSSYAFLLIARSLQGIGSSCSSVAGMGMLASVYTDDEERGNVMGIALGGLAMGVLVGPPFGSVLYEFVGKTAPFLVLAALVLLDGAIQLFVLQPSRVQPESQKGTPLTTLLKDPYILIAAGSICFANMGIAMLEPALPIWMMETMCSRKWQLGVAFLPASISYLIGTNIFGILAHKMGRWLCALLGMIIVGVSILCIPFAKNIYGLIAPNFGVGFAIGMVDSSMMPIMGYLVDLRHVSVYGSVYAIADVAFCMGYAIGPSAGGAIAKAIGFPWLMTIIGIIDILFAPLCFFLRSPPAKEEKMAILMDHNCPIKTKMYTQNNIQSYPIGEDEESESD</Protein_Seq>
    <DNA_Seq>AGAGCCGGACGGGGTAAACTGAGCGGCGGCGGCGGGGCGCTGGGGCGGAGACTGCGACCCGGAGCCGCCCGGACTGACGGAGCCCACTGCGGTGCGGGCGTTGGCGCGGGCACGGAGGACCCGGGCAGGCATCGCAAGCGACCCCGAGCGGAGCCCCGGAGCCATGGCCCTGAGCGAGCTGGCGCTGGTCCGCTGGCTGCAGGAGAGCCGCCGCTCGCGGAAGCTCATCCTGTTCATCGTGTTCCTGGCGCTGCTGCTGGACAACATGCTGCTCACTGTCGTGGTCCCCATCATCCCAAGTTATCTGTACAGCATTAAGCATGAGAAGAATGCTACAGAAATCCAGACGGCCAGGCCAGTGCACACTGCCTCCATCTCAGACAGCTTCCAGAGCATCTTCTCCTATTATGATAACTCGACTATGGTCACCGGGAATGCTACCAGAGACCTGACACTTCATCAGACCGCCACACAGCACATGGTGACCAACGCGTCCGCTGTTCCTTCCGACTGTCCCAGTGAAGACAAAGACCTCCTGAATGAAAACGTGCAAGTTGGTCTGTTGTTTGCCTCGAAAGCCACCGTCCAGCTCATCACCAACCCTTTCATAGGACTACTGACCAACAGAATTGGCTATCCAATTCCCATATTTGCGGGATTCTGCATCATGTTTGTCTCAACAATTATGTTTGCCTTCTCCAGCAGCTATGCCTTCCTGCTGATTGCCAGGTCGCTGCAGGGCATCGGCTCGTCCTGCTCCTCTGTGGCTGGGATGGGCATGCTTGCCAGTGTCTACACAGATGATGAAGAGAGAGGCAACGTCATGGGAATCGCCTTGGGAGGCCTGGCCATGGGGGTCTTAGTGGGCCCCCCCTTCGGGAGTGTGCTCTATGAGTTTGTGGGGAAGACGGCTCCGTTCCTGGTGCTGGCCGCCCTGGTACTCTTGGATGGAGCTATTCAGCTCTTTGTGCTCCAGCCGTCCCGGGTGCAGCCAGAGAGTCAGAAGGGGACACCCCTAACCACGCTGCTGAAGGACCCGTACATCCTCATTGCTGCAGGCTCCATCTGCTTTGCAAACATGGGCATCGCCATGCTGGAGCCAGCCCTGCCCATCTGGATGATGGAGACCATGTGTTCCCGAAAGTGGCAGCTGGGCGTTGCCTTCTTGCCAGCTAGTATCTCTTATCTCATTGGAACCAATATTTTTGGGATACTTGCACACAAAATGGGGAGGTGGCTTTGTGCTCTTCTGGGAATGATAATTGTTGGAGTCAGCATTTTATGTATTCCATTTGCAAAAAACATTTATGGACTCATAGCTCCGAACTTTGGAGTTGGTTTTGCAATTGGAATGGTGGATTCGTCAATGATGCCTATCATGGGCTACCTCGTAGACCTGCGGCACGTGTCCGTCTATGGGAGTGTGTACGCCATTGCGGATGTGGCATTTTGTATGGGGTATGCTATAGGTCCTTCTGCTGGTGGTGCTATTGCAAAGGCAATTGGATTTCCATGGCTCATGACAATTATTGGGATAATTGATATTCTTTTTGCCCCTCTCTGCTTTTTTCTTCGAAGTCCACCTGCCAAAGAAGAAAAAATGGCTATTCTCATGGATCACAACTGCCCTATTAAAACAAAAATGTACACTCAGAATAATATCCAGTCATATCCGATAGGTGAAGATGAAGAATCTGAAAGTGACTGAGATGAGATCCTCAAAAATCATCAAAGTGTTTAATTGTATAAAACAGTGTTTCCAGTGACACAACTCATCCAGAACTGTCTTAGTCATACCATCCATCCCTGGTGAAAGAGTAAAACCAAAGGTTATTATTTCCTTTCCATGGTTATGGTCGATTGCCAACAGCCTTATAAAGAAAAAGAAGCTTTTCTAGGGGTTTGTATAAATAGTGTTGAAACTTTATTTTATGTATTTAATTTTATTAAATATCATACAATATATTTTGATGAAATAGGTATTGTGTAAATCTATAAATATTTGAATCCAAACCAAATATAATTTTTTAACTTACATTAACAAACATTTGGGCAAAAATCATATTGGTAATGAGTGTTTAAAATTAAAGCACACATTATCTCTGAGACTCTTCCAACAAAGAGAAACTAGAATGAAGTCTGAAAAACAGAATCAAGTAAGACAGCATGTTATATAGTGACACTGAATGTTATTTAACTTGTAGTTACTATCAATATATTTATGCGTTAAACAGCTAGTTCTCTCAAGTGTAGAGGACAAGAACTTGTGTCAGTTATCTTTTGAATCCATAAATCTTAGCTGGCATTAGTTTTCTATGTAATCACCTACCTAGAGAGAGTTGTAAATTATATGTTAACATGTTATCTGGTTGGCAGCAAACACTAAAGCCAATAAAGGAAAAACAGTAAATGTTCCGAAAGCAGAGAAAAGCAACCAAACATATTGTTATGAACTAAAAGCTTTCCCTTTAAGATGCATACTTGTCTTACTGGATGAAGAAAATTGAGGGTACATGTACCTTATACTGTCAAGGTTGTTTAAACATGATAAGGTTAATCGCCATCTACTTCAAGTTTTAGAAAAGGAAACAAGAAGCTGAAAACAGCTGCTCTGACTTTAATATCTGACTATATCTTTGATCTGTTTGCAGGTCATCCAAGTGTTTTCTAGGAATATATTTATTTTAGGTTGTCTGAAACTACTATTTTTTAGACTCCTGAAAGTTGTTCACATCAATGTGAAGACAAATTTTAAATGAAAATGAAGAATGAAATTATGTCTTGAATCATATATTAAGAAGTAAAAATAATAGTGATCAGGCAGAAAAGAAAAATGGAACATCTAAAAATGTATGTGCTAACTATATCATCCAGTGTGCAGTGTTGTGTATTTTTCTAAGCATGACAACATTGATGTGCCTTTTCAGTGTAACAGCAAATACTGTTAGTGAACATTGTCAATTTATGTCATTTTGTTAAGAGATATGACTGGAGTGTGCAGTGTGGAATGTCTCTAATACTACTTGTGAATCCTGCAGTTCTATAATCATAAACAAAAATTACTTAGTTTCGTTAAGCTAAGATTGTGTTTGTGTTAACTTCGACATCAAGGAGCAAAGAACTTTAGAACAGACTCCTCAATCTTGTGACTTTCTTATTCTCTAGGAAAGTAACACTTCGTTTCATGAAGCTTTTCTGTGGGGCTTCGATTATTTCAAGTCTGGTTTCTAAGTGCAGTGTGTTTGAAGCAAACGAACTTCCAACTCACTTATTTGGCATTGGGCAACTTGGCCAAGTCTGCCACTTTGGAAGATGGCTCTGGAGGAAACTCTCATATGGCTAAAAAGGCAGGCTAGTTTCTTACTTCTACAGGGGTAGAGCCTTAAAAAAGAACGTGCTACAAATTGGTTCTCTTTGAGGGTTTCTGGTTCTCCCTGCCCCCAATACCATATACTTTATTGCAATTTTATTTTTGCCTTTACGGCTCTGTGTCTTTCTGCAAGAAGGCCTGGCAAAGGTATGCCTGCTGTTGGTCCCTCGGGATAAGATAAAATATAAATAAAACCTTCAGAACTGTTTTGGAGCAAAAGATAGCTTGTACTTGGGGAAAAAAATTCTAAGTTCTTTTATATGACTAATATTCTTGGTTAGCAAGACTGGAAAGAGGTGTTTTTTTAAAATGTACATACCAGAACAAAGAACATACAGCTCTCTGAACATTTATTTTTTGAACAGAGGTGGTTTTTATGTTTGGACCTGGTAATACAGATACAAAAACTTTAATGAGGTAGCAATGAATATTCAACTGTTTGACTGCTAAGTGTATCTGTCCATATTTTAGCAAGTTTACTTAATAAATCTTCTGAACCATGAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Neuronal cell body</CellLocal>
      <Ontology_ID>GO:0043025</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic vesicle</CellLocal>
      <Ontology_ID>GO:0031410</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic vesicle membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Synaptic vesicle membrane</CellLocal>
      <Ontology_ID>GO:0030672</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Dense core granule</CellLocal>
      <Ontology_ID>GO:0031045</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Clathrin sculpted monoamine transport vesicle membrane</CellLocal>
      <Ontology_ID>GO:0070083</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Terminal button</CellLocal>
      <Ontology_ID>GO:0043195</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SLC18A2</Gene_Name>
    <Gene_Alias>SVMT; VMAT2</Gene_Alias>
    <Gene_ID>6571</Gene_ID>
    <Genbank_ACCN>NM_003054</Genbank_ACCN>
    <Protein_ACCN>NP_003045</Protein_ACCN>
    <HGNC_ID>10935</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/6571</Gene_URL>
    <UCSC_ID>uc001ldd.2</UCSC_ID>
    <EMBL_ID>ENSG00000165646</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Torsion Dystonia</Disease_Name>
      <Disease_Detail>Torsion Dystonia</Disease_Detail>
      <Disease_DB>TRS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/torsion_dystonia?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cocaine Dependence</Disease_Name>
      <Disease_Detail>Cocaine Dependence</Disease_Detail>
      <Disease_DB>CCN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cocaine_dependence?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Brain Dopamine-Serotonin Vesicular Transport Disease</Disease_Name>
      <Disease_Detail>Brain Dopamine-Serotonin Vesicular Transport Disease</Disease_Detail>
      <Disease_DB>BRN112</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/brain_dopamine_serotonin_vesicular_transport_disease?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lewy Body Dementia</Disease_Name>
      <Disease_Detail>Lewy Body Dementia</Disease_Detail>
      <Disease_DB>LWY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lewy_body_dementia?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Zollinger-Ellison Syndrome</Disease_Name>
      <Disease_Detail>Zollinger-Ellison Syndrome</Disease_Detail>
      <Disease_DB>ZLL002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/zollinger_ellison_syndrome?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson's Disease</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinsons_disease?search=SLC18A2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of Synaptic vesicular amine transporter</PDB_Title>
      <PDB_ID>ASD10980000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04726</Pathway_ID>
      <Pathway_Title>Serotonergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05012</Pathway_ID>
      <Pathway_Title>Parkinson's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04728</Pathway_ID>
      <Pathway_Title>Dopaminergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
  </Network_List>
  <Create_Date>2013-11-12</Create_Date>
</Organism_Record>